Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

797 ARTÍCULOS , VIENDO DEL 271 AL 285

The Advancements of Marine Natural Products in the Treatment of Alzheimer's Disease: A Study Based on Cell and Animal Experiments

Jia C, Chai J, Zhang S, Sun Y, He L, Sang Z, Chen D, Zheng X.

Mar Drugs. 2025 Feb 20;23(3):91. doi: 10.3390/md23030091.

Neuroprotective Properties of Clove (Syzygium aromaticum): State of the Art and Future Pharmaceutical Applications for Alzheimer's Disease

Sargsyan T, Simonyan HM, Stepanyan L, Tsaturyan A, Vicidomini C, Pastore R, Guerra G, Roviello GN.

Biomolecules. 2025 Mar 20;15(3):452. doi: 10.3390/biom15030452.

Nrf2/Bach1 signaling axis: A promising multifaceted therapeutic strategy for Alzheimer's disease

Soni P, Sharma SM, Pieper AA, Paul BD, Thomas B.

Neurotherapeutics. 2025 Apr;22(3):e00586. doi: 10.1016/j.neurot.2025.e00586. Epub 2025 Apr 7.

Reevaluating Alzheimer's disease treatment: Can phytochemicals bridge the therapeutic Gap?

Roy KK, Mehta DK, Das R.

Neuroscience. 2025 May 24;575:1-18. doi: 10.1016/j.neuroscience.2025.04.014. Epub 2025 Apr 10.

Circular RNAs, miRNAs, and Exosomes: Their Roles and Importance in Amyloid-Beta and Tau Pathologies in Alzheimer's Disease

Pala M, Yilmaz SG.

Neural Plast. 2025 Apr 8;2025:9581369. doi: 10.1155/np/9581369. eCollection 2025.

Targeting of PP2 A/GSK3β/PTEN Axis in Alzheimer Disease: The Mooting Evidence, Divine, and Devil

Alqahtani SM, Al-Kuraishy HM, Al-Gareeb AI, Abdel-Fattah MM, Alsaiari AA, Alruwaili M, Papadakis M, Alexiou A, Batiha GE.

Cell Mol Neurobiol. 2025 Apr 18;45(1):36. doi: 10.1007/s10571-025-01554-0.

Tailoring MAPK Pathways: New Therapeutic Avenues for Treating Alzheimer's Disease

Sharma A, Mehra V, Kumar V, Jain A, Prakash H.

Mol Neurobiol. 2025 Nov;62(11):14315-14343. doi: 10.1007/s12035-025-04919-0. Epub 2025 Apr 21.

P-glycoprotein and Alzheimer's Disease: Threats and Opportunities

Asante JJ Jr, Barger SW.

ASN Neuro. 2025;17(1):2495632. doi: 10.1080/17590914.2025.2495632. Epub 2025 Apr 23.

Iridoid glycosides in kidney-tonifying Chinese medicinal herbs: Mechanisms and implications for Alzheimer's disease therapy

Qu Y, Ding M, Zhang M, Zheng L, Hu B, An H.

J Ethnopharmacol. 2025 May 28;348:119870. doi: 10.1016/j.jep.2025.119870. Epub 2025 Apr 25.

Ferroptosis in Alzheimer's Disease: The Regulatory Role of Glial Cells

Xu J, Shen R, Qian M, Zhou Z, Xie B, Jiang Y, Yu Y, Dong W.

J Integr Neurosci. 2025 Apr 24;24(4):25845. doi: 10.31083/JIN25845.

Role of mGluR7 in Alzheimer's disease: pathophysiological insights and therapeutic approaches

Hunjan G, Aran KR.

Inflammopharmacology. 2025 Jun;33(6):2977-2995. doi: 10.1007/s10787-025-01765-3. Epub 2025 May 3.

Research progress of cell senescence in Alzheimer's disease: mechanisms and therapy

Cai J, Yang L, Xu Y, Wang L, Zhang M, Qiao J, Xu Q, Zhu H, Cai M.

Eur J Pharmacol. 2025 Sep 5;1002:177697. doi: 10.1016/j.ejphar.2025.177697. Epub 2025 May 2.

Recent Advances in Drug Development for Alzheimer's Disease: A Comprehensive Review

Xing H, Yue S, Qin R, Du X, Wu Y, Zhangsun D, Luo S.

Int J Mol Sci. 2025 Apr 21;26(8):3905. doi: 10.3390/ijms26083905.

NGF-based cholinergic therapies in Alzheimer disease

Mitra S, Gera R, Eriksdotter M.

Handb Clin Neurol. 2025;211:123-135. doi: 10.1016/B978-0-443-19088-9.00007-X.

Evaluation of Illumina and Oxford Nanopore Sequencing for the Study of DNA Methylation in Alzheimer's Disease and Frontotemporal Dementia

Pagano L, Lagrotteria D, Facconi A, Saraceno C, Longobardi A, Bellini S, Ingannato A, Bagnoli S, Ducci T, Mingrino A, Laganà V, Paparazzo E, Borroni B, Maletta R, Nacmias B, Montesanto A, Ghidoni R.

Int J Mol Sci. 2025 Apr 28;26(9):4198. doi: 10.3390/ijms26094198.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias